Trial in Elderly With Musculoskeletal Problems Due to Underlying Sarcopenia - Faeces to Unravel Gut and Inflammation Translationally

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The overall aim of the TEMPUS-FUGIT study is to assess gut microbiota composition in older persons without sarcopenia and to determine the relationship with and between intestinal and systemic inflammation and with sarcopenia-defining parameters (muscle mass, muscle strength and physical performance). The gut microbiota of older persons without sarcopenia (included in TEMPUS-FUGIT) will be compared with the gut microbiota of older people with sarcopenia, participating in the Exercise and Nutrition for Healthy AgeiNg (ENHANce) study (NCT03649698).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: t
View:

• Male or female persons without probable, confirmed or severe sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP2): no reduced muscle strength measured by chair stand test or hand grips strength

• 65 years or older

• Community-dwelling elderly or assisted living

• Dutch speaking

Locations
Other Locations
Belgium
UZ Leuven
RECRUITING
Leuven
Contact Information
Primary
Jolan Dupont, MD
jolan.dupont@uzleuven.be
+32 16 34 32 01
Backup
Laura Vercauteren, MSc
laura.vercauteren@kuleuven.be
+32 16 34 38 67
Time Frame
Start Date: 2021-09-21
Estimated Completion Date: 2025-11
Participants
Target number of participants: 110
Treatments
Older adults without sarcopenia
Healthy volunteers aged 65+ years who do not fulfill diagnostic criteria for sarcopenia, according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2)
Related Therapeutic Areas
Sponsors
Collaborators: Research Foundation Flanders, KU Leuven
Leads: Universitaire Ziekenhuizen KU Leuven

This content was sourced from clinicaltrials.gov